InsidersTradesSigma
인바이오 Stock: price and insider trades · South Korea · DART (FSS)
Track the 인바이오 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Chemicals sector, 인바이오 has recorded 51 reports. Market capitalisation: €21.6bn. The latest transaction was disclosed on 7 July 2026 (Other). Among the most active insiders: 이혁재. Every trade is accessible without an account.
51
Insider Decl.
0
Thresholds
€14,430
36 ops.
Buy Volume
·
0 ops.
Sell Volume
31Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 13,295 of 26,211 companies
51.5
score / 100
Value66
Quality37
FCF yld9.2%
Earn yld4.6%
EV/EBITDA10.4x
ROE1.8%
Gross mgn35%
Net mgn3.0%
Debt/EBITDA4.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 7 July 2026
Declarations51 total
25 of 51 declarations
About 인바이오
Inbio is a company specializing in the chemical and materials sector. It is listed on the XKRX market.